RAB25 confers resistance to chemotherapy by altering mitochondrial apoptosis signaling in ovarian cancer cells

APOPTOSIS ◽  
2020 ◽  
Vol 25 (11-12) ◽  
pp. 799-816
Author(s):  
Sehime Gulsun Temel ◽  
Aslı Giray ◽  
Bahriye Karakas ◽  
Ozgur Gul ◽  
Ilknur Kozanoglu ◽  
...  
2020 ◽  
Vol Volume 13 ◽  
pp. 5375-5386 ◽  
Author(s):  
Xiaohong Deng ◽  
Yi Chen ◽  
Zhao Liu ◽  
Jingning Xu

Cancers ◽  
2019 ◽  
Vol 11 (4) ◽  
pp. 557 ◽  
Author(s):  
Margie N. Sutton ◽  
Gilbert Y. Huang ◽  
Xiaowen Liang ◽  
Rajesh Sharma ◽  
Albert S. Reger ◽  
...  

Autophagy can protect cancer cells from acute starvation and enhance resistance to chemotherapy. Previously, we reported that autophagy plays a critical role in the survival of dormant, drug resistant ovarian cancer cells using human xenograft models and correlated the up-regulation of autophagy and DIRAS3 expression in clinical samples obtained during “second look” operations. DIRAS3 is an imprinted tumor suppressor gene that encodes a 26 kD GTPase with homology to RAS that inhibits cancer cell proliferation and motility. Re-expression of DIRAS3 in ovarian cancer xenografts also induces dormancy and autophagy. DIRAS3 can bind to Beclin1 forming the Autophagy Initiation Complex that triggers autophagosome formation. Both the N-terminus of DIRAS3 (residues 15–33) and the switch II region of DIRAS3 (residues 93–107) interact directly with BECN1. We have identified an autophagy-inhibiting peptide based on the switch II region of DIRAS3 linked to Tat peptide that is taken up by ovarian cancer cells, binds Beclin1 and inhibits starvation-induced DIRAS3-mediated autophagy.


2018 ◽  
Author(s):  
F Guo ◽  
Z Yang ◽  
J Xu ◽  
J Sehouli ◽  
AE Albers ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document